Cellebrite DI Ltd. (NASDAQ:CLBT) Receives $20.29 Consensus Target Price from Analysts

Shares of Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) have been given a consensus recommendation of "Buy" by the eight analysts that are presently covering the stock, MarketBeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $20.29.

A number of research analysts have issued reports on CLBT shares. Lake Street Capital raised their price target on shares of Cellebrite DI from $13.50 to $17.00 and gave the stock a "buy" rating in a report on Friday, August 16th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Cellebrite DI from $15.00 to $18.00 and gave the stock a "buy" rating in a report on Friday, August 16th. JPMorgan Chase & Co. raised their target price on shares of Cellebrite DI from $21.00 to $22.00 and gave the stock an "overweight" rating in a report on Thursday, November 7th. Craig Hallum raised their target price on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a "buy" rating in a report on Thursday, November 7th. Finally, Needham & Company LLC raised their target price on shares of Cellebrite DI from $17.00 to $21.00 and gave the stock a "buy" rating in a report on Thursday, November 7th.

Institutional Investors Weigh In On Cellebrite DI

Several large investors have recently added to or reduced their stakes in CLBT. Quarry LP purchased a new stake in Cellebrite DI during the 3rd quarter worth approximately $27,000. Point72 Asia Singapore Pte. Ltd. increased its stake in Cellebrite DI by 59.6% during the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company's stock worth $33,000 after buying an additional 1,017 shares during the period. Advisors Asset Management Inc. increased its stake in Cellebrite DI by 130.5% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company's stock worth $52,000 after buying an additional 1,742 shares during the period. Public Employees Retirement Association of Colorado purchased a new stake in Cellebrite DI during the 2nd quarter worth approximately $71,000. Finally, Pathway Financial Advisers LLC increased its position in shares of Cellebrite DI by 1,583.8% in the 3rd quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company's stock valued at $74,000 after purchasing an additional 4,118 shares during the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Cellebrite DI Stock Performance

Shares of CLBT opened at $17.70 on Monday. The company has a 50 day moving average price of $17.74 and a 200-day moving average price of $14.57. Cellebrite DI has a fifty-two week low of $7.64 and a fifty-two week high of $21.00. The stock has a market capitalization of $3.64 billion, a PE ratio of -11.42, a PEG ratio of 2.41 and a beta of 1.50.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last posted its earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The company had revenue of $106.90 million during the quarter, compared to analysts' expectations of $102.06 million. During the same quarter in the prior year, the company posted $0.09 earnings per share. Cellebrite DI's revenue for the quarter was up 27.0% compared to the same quarter last year. Equities research analysts forecast that Cellebrite DI will post 0.32 EPS for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.